Concepedia

Publication | Open Access

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

DOIFull Paper Access

2.8K

Citations

18

References

2011

Year

José Baselga, Mario Campone, Martine Piccart, Howard A. Burris, Hope S. Rugo, Tarek Sahmoud, Shinzaburo Noguchi, Michael Gnant, Kathleen I. Pritchard, Fabienne Lebrun,
New England Journal of Medicine

Abstract

Everolimus combined with an aromatase inhibitor improved progression-free survival in patients with hormone-receptor-positive advanced breast cancer previously treated with nonsteroidal aromatase inhibitors. (Funded by Novartis; BOLERO-2 ClinicalTrials.gov number, NCT00863655.).

References

YearCitations

Page 1